Rss Feed

Grandparents can play a critical role in helping mediate their grandchildren's media use and serve as an ally for their families, according to a Rutgers study.

Rodney Scott, MBChB, MRCP, DipStat, PhD, Division Chief of Neurology, Nemours Children's Health, Delaware Valley, has received a prestigious National Institutes of Health (NIH) Director's Transformative Research Award.

A low-fat vegan diet that doesn't limit calories or carbohydrates could help people with type 1 diabetes reduce insulin use and insulin costs, according to new research by the Physicians Committee for Responsible Medicine published in BMC Nutrition.

For children and young adults diagnosed with osteosarcoma, a common type of bone cancer for that age group, the odds of survival can be devastatingly low (20-30%) when the disease spreads to the lungs.

More than a third of Canadian teens say climate change is impacting their mental health, according to a national study led by Athabasca University researchers.

There's mounting evidence that popular drugs prescribed for diabetes management and weight loss - better known by trade names like Ozempic and Wegovy - could be effective in reducing alcohol use.

Child maltreatment, which includes abuse and neglect, is one of the most serious public health concerns worldwide.

Immune checkpoint inhibitors are well known as a form of cancer treatment. Researchers at UZH have now identified a new, important function of these inhibitors: promotion of tissue healing.

Older adults, especially those living with health conditions, who hold positive views about aging are more likely to engage in vigorous physical activity, according to a study led by the University of Surrey.

Combining an epigenetic therapy with an anti-PD-1 antibody, which uses the body's natural response to viral infections, showed promising results in patients with relapsed or refractory natural killer/T-cell lymphoma (R/R NKTL), a rare and aggressive cancer with limited treatment options.

The global drug use disorder deaths have more than doubled since 1990, even as new addiction cases declined, highlighting a widening gap in harm reduction and treatment access, especially in wealthy nations.

In a compelling Genomic Press Interview published today in Genomic Psychiatry, Dr. Najaf Amin unveils transformative insights that fundamentally reshape international understanding of depression genetics.

A comprehensive peer-reviewed invited review published today in Psychedelics by Dr. Kenji Hashimoto and colleagues (Dr. Mingming Zhao and Dr. Jianjun Yang) synthesizes the evolving landscape of MDMA-assisted psychotherapy, examining robust clinical evidence in treatment-resistant posttraumatic stress disorder while identifying promising applications in autism spectrum disorder, eating disorders, and existential distress

The brain's mechanisms for repairing injuries caused by trauma or degenerative diseases are not yet known in detail.

Liver cancer is one of the world's deadliest malignancies, ranking as the third leading cause of cancer-related death.

Since ancient times, it was thought that painful stomach ulcers were caused by eating spicy foods or having an unhealthy diet.

Peginterferon-α treatment exhibits low rates of the serological conversion rate of hepatitis B e antigen (HBeAg) and the negative conversion rate of hepatitis B virus (HBV) DNA, with significant myelosuppression leading to treatment discontinuation in some patients.

For countless millions across the globe, commuting to work or school is an everyday routine. But during a pandemic, the practice can contribute enormously to the spread of infectious disease, a fact that many traditional metapopulation models often overlook because they are designed primarily for migration and treat people as if they rarely move locally.

Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than enough cells to replace damaged blood vessels or nourish organs for transplantation, according to a preclinical study by Weill Cornell Medicine investigators.

About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of the disease, with symptoms that worsen continuously or after periods of remission.